 | • レポートコード：MRC2-11QY05696 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は内分泌薬のグローバル市場について調査・分析したレポートです。種類別（糖尿病治療薬、テストステロン補充療法薬、ヒト成長ホルモン薬、甲状腺ホルモン障害薬）市場規模、用途別（病院、商業研究所、外来診療センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別内分泌薬の競争状況、市場シェア ・世界の内分泌薬市場：種類別市場規模 2015年-2020年（糖尿病治療薬、テストステロン補充療法薬、ヒト成長ホルモン薬、甲状腺ホルモン障害薬） ・世界の内分泌薬市場：種類別市場規模予測 2021年-2026年（糖尿病治療薬、テストステロン補充療法薬、ヒト成長ホルモン薬、甲状腺ホルモン障害薬） ・世界の内分泌薬市場：用途別市場規模 2015年-2020年（病院、商業研究所、外来診療センター、その他） ・世界の内分泌薬市場：用途別市場規模予測 2021年-2026年（病院、商業研究所、外来診療センター、その他） ・北米の内分泌薬市場分析：米国、カナダ ・ヨーロッパの内分泌薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの内分泌薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の内分泌薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの内分泌薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：AbbVie、AstraZeneca、Eli Lilly、Merck、Novo Nordisk、Sanofi ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Endocrinology drugs are used to treat hormonal problems such as hypothyroidism, diabetes and others.
One of the market drivers is increase in prevalence of endocrine hormone-related diseases.
Market Analysis and Insights: Global Endocrinology Drugs Market
The global Endocrinology Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Endocrinology Drugs Scope and Market Size
Endocrinology Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Endocrinology Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Endocrinology Drugs market is segmented into
Diabetes Drugs
Testosterone Replacement Drugs
Human Growth Hormone Drugs
Thyroid Hormone Disorder Drugs
Segment by Application, the Endocrinology Drugs market is segmented into
Hospitals
Commercial Laboratories
Ambulatory Care Centres
Other Setting
Regional and Country-level Analysis
The Endocrinology Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Endocrinology Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Endocrinology Drugs Market Share Analysis
Endocrinology Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Endocrinology Drugs business, the date to enter into the Endocrinology Drugs market, Endocrinology Drugs product introduction, recent developments, etc.
The major vendors covered:
AbbVie
AstraZeneca
Eli Lilly
Merck
Novo Nordisk
Sanofi
…
1 Study Coverage
1.1 Endocrinology Drugs Product Introduction
1.2 Market Segments
1.3 Key Endocrinology Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Endocrinology Drugs Market Size Growth Rate by Type
1.4.2 Diabetes Drugs
1.4.3 Testosterone Replacement Drugs
1.4.4 Human Growth Hormone Drugs
1.4.5 Thyroid Hormone Disorder Drugs
1.5 Market by Application
1.5.1 Global Endocrinology Drugs Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Commercial Laboratories
1.5.4 Ambulatory Care Centres
1.5.5 Other Setting
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Endocrinology Drugs Market Size, Estimates and Forecasts
2.1.1 Global Endocrinology Drugs Revenue 2015-2026
2.1.2 Global Endocrinology Drugs Sales 2015-2026
2.2 Global Endocrinology Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Endocrinology Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Endocrinology Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Endocrinology Drugs Competitor Landscape by Players
3.1 Endocrinology Drugs Sales by Manufacturers
3.1.1 Endocrinology Drugs Sales by Manufacturers (2015-2020)
3.1.2 Endocrinology Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Endocrinology Drugs Revenue by Manufacturers
3.2.1 Endocrinology Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Endocrinology Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Endocrinology Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Endocrinology Drugs Revenue in 2019
3.2.5 Global Endocrinology Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Endocrinology Drugs Price by Manufacturers
3.4 Endocrinology Drugs Manufacturing Base Distribution, Product Types
3.4.1 Endocrinology Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Endocrinology Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Endocrinology Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Endocrinology Drugs Market Size by Type (2015-2020)
4.1.1 Global Endocrinology Drugs Sales by Type (2015-2020)
4.1.2 Global Endocrinology Drugs Revenue by Type (2015-2020)
4.1.3 Endocrinology Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Endocrinology Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Endocrinology Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Endocrinology Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Endocrinology Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Endocrinology Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Endocrinology Drugs Market Size by Application (2015-2020)
5.1.1 Global Endocrinology Drugs Sales by Application (2015-2020)
5.1.2 Global Endocrinology Drugs Revenue by Application (2015-2020)
5.1.3 Endocrinology Drugs Price by Application (2015-2020)
5.2 Endocrinology Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Endocrinology Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Endocrinology Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Endocrinology Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Endocrinology Drugs by Country
6.1.1 North America Endocrinology Drugs Sales by Country
6.1.2 North America Endocrinology Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Endocrinology Drugs Market Facts & Figures by Type
6.3 North America Endocrinology Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Endocrinology Drugs by Country
7.1.1 Europe Endocrinology Drugs Sales by Country
7.1.2 Europe Endocrinology Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Endocrinology Drugs Market Facts & Figures by Type
7.3 Europe Endocrinology Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Endocrinology Drugs by Region
8.1.1 Asia Pacific Endocrinology Drugs Sales by Region
8.1.2 Asia Pacific Endocrinology Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Endocrinology Drugs Market Facts & Figures by Type
8.3 Asia Pacific Endocrinology Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Endocrinology Drugs by Country
9.1.1 Latin America Endocrinology Drugs Sales by Country
9.1.2 Latin America Endocrinology Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Endocrinology Drugs Market Facts & Figures by Type
9.3 Central & South America Endocrinology Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Endocrinology Drugs by Country
10.1.1 Middle East and Africa Endocrinology Drugs Sales by Country
10.1.2 Middle East and Africa Endocrinology Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Endocrinology Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Endocrinology Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 AbbVie
11.1.1 AbbVie Corporation Information
11.1.2 AbbVie Description and Business Overview
11.1.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AbbVie Endocrinology Drugs Products Offered
11.1.5 AbbVie Related Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Corporation Information
11.2.2 AstraZeneca Description and Business Overview
11.2.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.2.4 AstraZeneca Endocrinology Drugs Products Offered
11.2.5 AstraZeneca Related Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Corporation Information
11.3.2 Eli Lilly Description and Business Overview
11.3.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Eli Lilly Endocrinology Drugs Products Offered
11.3.5 Eli Lilly Related Developments
11.4 Merck
11.4.1 Merck Corporation Information
11.4.2 Merck Description and Business Overview
11.4.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Merck Endocrinology Drugs Products Offered
11.4.5 Merck Related Developments
11.5 Novo Nordisk
11.5.1 Novo Nordisk Corporation Information
11.5.2 Novo Nordisk Description and Business Overview
11.5.3 Novo Nordisk Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Novo Nordisk Endocrinology Drugs Products Offered
11.5.5 Novo Nordisk Related Developments
11.6 Sanofi
11.6.1 Sanofi Corporation Information
11.6.2 Sanofi Description and Business Overview
11.6.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Sanofi Endocrinology Drugs Products Offered
11.6.5 Sanofi Related Developments
11.1 AbbVie
11.1.1 AbbVie Corporation Information
11.1.2 AbbVie Description and Business Overview
11.1.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AbbVie Endocrinology Drugs Products Offered
11.1.5 AbbVie Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Endocrinology Drugs Market Estimates and Projections by Region
12.1.1 Global Endocrinology Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Endocrinology Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Endocrinology Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Endocrinology Drugs Sales Forecast (2021-2026)
12.2.2 North America: Endocrinology Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Endocrinology Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Endocrinology Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Endocrinology Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Endocrinology Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Endocrinology Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Endocrinology Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Endocrinology Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Endocrinology Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Endocrinology Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Endocrinology Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Endocrinology Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Endocrinology Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Endocrinology Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Endocrinology Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Endocrinology Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Endocrinology Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Endocrinology Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Endocrinology Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Endocrinology Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Endocrinology Drugs Market Segments
Table 2. Ranking of Global Top Endocrinology Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Endocrinology Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Diabetes Drugs
Table 5. Major Manufacturers of Testosterone Replacement Drugs
Table 6. Major Manufacturers of Human Growth Hormone Drugs
Table 7. Major Manufacturers of Thyroid Hormone Disorder Drugs
Table 8. Global Endocrinology Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 9. Global Endocrinology Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 10. Global Endocrinology Drugs Sales by Regions 2015-2020 (K Units)
Table 11. Global Endocrinology Drugs Sales Market Share by Regions (2015-2020)
Table 12. Global Endocrinology Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Endocrinology Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 14. Global Endocrinology Drugs Sales Share by Manufacturers (2015-2020)
Table 15. Global Endocrinology Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Endocrinology Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Endocrinology Drugs as of 2019)
Table 17. Endocrinology Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Endocrinology Drugs Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Endocrinology Drugs Price (2015-2020) (USD/Unit)
Table 20. Endocrinology Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Endocrinology Drugs Product Type
Table 22. Date of International Manufacturers Enter into Endocrinology Drugs Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Endocrinology Drugs Sales by Type (2015-2020) (K Units)
Table 25. Global Endocrinology Drugs Sales Share by Type (2015-2020)
Table 26. Global Endocrinology Drugs Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Endocrinology Drugs Revenue Share by Type (2015-2020)
Table 28. Endocrinology Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 29. Global Endocrinology Drugs Sales by Application (2015-2020) (K Units)
Table 30. Global Endocrinology Drugs Sales Share by Application (2015-2020)
Table 31. North America Endocrinology Drugs Sales by Country (2015-2020) (K Units)
Table 32. North America Endocrinology Drugs Sales Market Share by Country (2015-2020)
Table 33. North America Endocrinology Drugs Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Endocrinology Drugs Revenue Market Share by Country (2015-2020)
Table 35. North America Endocrinology Drugs Sales by Type (2015-2020) (K Units)
Table 36. North America Endocrinology Drugs Sales Market Share by Type (2015-2020)
Table 37. North America Endocrinology Drugs Sales by Application (2015-2020) (K Units)
Table 38. North America Endocrinology Drugs Sales Market Share by Application (2015-2020)
Table 39. Europe Endocrinology Drugs Sales by Country (2015-2020) (K Units)
Table 40. Europe Endocrinology Drugs Sales Market Share by Country (2015-2020)
Table 41. Europe Endocrinology Drugs Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Endocrinology Drugs Revenue Market Share by Country (2015-2020)
Table 43. Europe Endocrinology Drugs Sales by Type (2015-2020) (K Units)
Table 44. Europe Endocrinology Drugs Sales Market Share by Type (2015-2020)
Table 45. Europe Endocrinology Drugs Sales by Application (2015-2020) (K Units)
Table 46. Europe Endocrinology Drugs Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Endocrinology Drugs Sales by Region (2015-2020) (K Units)
Table 48. Asia Pacific Endocrinology Drugs Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Endocrinology Drugs Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Endocrinology Drugs Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Endocrinology Drugs Sales by Type (2015-2020) (K Units)
Table 52. Asia Pacific Endocrinology Drugs Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Endocrinology Drugs Sales by Application (2015-2020) (K Units)
Table 54. Asia Pacific Endocrinology Drugs Sales Market Share by Application (2015-2020)
Table 55. Latin America Endocrinology Drugs Sales by Country (2015-2020) (K Units)
Table 56. Latin America Endocrinology Drugs Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Endocrinology Drugs Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Endocrinology Drugs Revenue Market Share by Country (2015-2020)
Table 59. Latin America Endocrinology Drugs Sales by Type (2015-2020) (K Units)
Table 60. Latin America Endocrinology Drugs Sales Market Share by Type (2015-2020)
Table 61. Latin America Endocrinology Drugs Sales by Application (2015-2020) (K Units)
Table 62. Latin America Endocrinology Drugs Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Endocrinology Drugs Sales by Country (2015-2020) (K Units)
Table 64. Middle East and Africa Endocrinology Drugs Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Endocrinology Drugs Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Endocrinology Drugs Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Endocrinology Drugs Sales by Type (2015-2020) (K Units)
Table 68. Middle East and Africa Endocrinology Drugs Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Endocrinology Drugs Sales by Application (2015-2020) (K Units)
Table 70. Middle East and Africa Endocrinology Drugs Sales Market Share by Application (2015-2020)
Table 71. AbbVie Corporation Information
Table 72. AbbVie Description and Major Businesses
Table 73. AbbVie Endocrinology Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 74. AbbVie Product
Table 75. AbbVie Recent Development
Table 76. AstraZeneca Corporation Information
Table 77. AstraZeneca Description and Major Businesses
Table 78. AstraZeneca Endocrinology Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 79. AstraZeneca Product
Table 80. AstraZeneca Recent Development
Table 81. Eli Lilly Corporation Information
Table 82. Eli Lilly Description and Major Businesses
Table 83. Eli Lilly Endocrinology Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 84. Eli Lilly Product
Table 85. Eli Lilly Recent Development
Table 86. Merck Corporation Information
Table 87. Merck Description and Major Businesses
Table 88. Merck Endocrinology Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 89. Merck Product
Table 90. Merck Recent Development
Table 91. Novo Nordisk Corporation Information
Table 92. Novo Nordisk Description and Major Businesses
Table 93. Novo Nordisk Endocrinology Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 94. Novo Nordisk Product
Table 95. Novo Nordisk Recent Development
Table 96. Sanofi Corporation Information
Table 97. Sanofi Description and Major Businesses
Table 98. Sanofi Endocrinology Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 99. Sanofi Product
Table 100. Sanofi Recent Development
Table 101. Global Endocrinology Drugs Sales Forecast by Regions (2021-2026) (K Units)
Table 102. Global Endocrinology Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 103. Global Endocrinology Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 104. Global Endocrinology Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 105. North America: Endocrinology Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 106. North America: Endocrinology Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 107. Europe: Endocrinology Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 108. Europe: Endocrinology Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 109. Asia Pacific: Endocrinology Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 110. Asia Pacific: Endocrinology Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 111. Latin America: Endocrinology Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 112. Latin America: Endocrinology Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 113. Middle East and Africa: Endocrinology Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 114. Middle East and Africa: Endocrinology Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 116. Key Challenges
Table 117. Market Risks
Table 118. Main Points Interviewed from Key Endocrinology Drugs Players
Table 119. Endocrinology Drugs Customers List
Table 120. Endocrinology Drugs Distributors List
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Endocrinology Drugs Product Picture
Figure 2. Global Endocrinology Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Diabetes Drugs Product Picture
Figure 4. Testosterone Replacement Drugs Product Picture
Figure 5. Human Growth Hormone Drugs Product Picture
Figure 6. Thyroid Hormone Disorder Drugs Product Picture
Figure 7. Global Endocrinology Drugs Sales Market Share by Application in 2020 & 2026
Figure 8. Hospitals
Figure 9. Commercial Laboratories
Figure 10. Ambulatory Care Centres
Figure 11. Other Setting
Figure 12. Endocrinology Drugs Report Years Considered
Figure 13. Global Endocrinology Drugs Market Size 2015-2026 (US$ Million)
Figure 14. Global Endocrinology Drugs Sales 2015-2026 (K Units)
Figure 15. Global Endocrinology Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Endocrinology Drugs Sales Market Share by Region (2015-2020)
Figure 17. Global Endocrinology Drugs Sales Market Share by Region in 2019
Figure 18. Global Endocrinology Drugs Revenue Market Share by Region (2015-2020)
Figure 19. Global Endocrinology Drugs Revenue Market Share by Region in 2019
Figure 20. Global Endocrinology Drugs Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Endocrinology Drugs Revenue in 2019
Figure 22. Endocrinology Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Endocrinology Drugs Sales Market Share by Type (2015-2020)
Figure 24. Global Endocrinology Drugs Sales Market Share by Type in 2019
Figure 25. Global Endocrinology Drugs Revenue Market Share by Type (2015-2020)
Figure 26. Global Endocrinology Drugs Revenue Market Share by Type in 2019
Figure 27. Global Endocrinology Drugs Market Share by Price Range (2015-2020)
Figure 28. Global Endocrinology Drugs Sales Market Share by Application (2015-2020)
Figure 29. Global Endocrinology Drugs Sales Market Share by Application in 2019
Figure 30. Global Endocrinology Drugs Revenue Market Share by Application (2015-2020)
Figure 31. Global Endocrinology Drugs Revenue Market Share by Application in 2019
Figure 32. North America Endocrinology Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 33. North America Endocrinology Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Endocrinology Drugs Sales Market Share by Country in 2019
Figure 35. North America Endocrinology Drugs Revenue Market Share by Country in 2019
Figure 36. U.S. Endocrinology Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 37. U.S. Endocrinology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Endocrinology Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 39. Canada Endocrinology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Endocrinology Drugs Market Share by Type in 2019
Figure 41. North America Endocrinology Drugs Market Share by Application in 2019
Figure 42. Europe Endocrinology Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 43. Europe Endocrinology Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Endocrinology Drugs Sales Market Share by Country in 2019
Figure 45. Europe Endocrinology Drugs Revenue Market Share by Country in 2019
Figure 46. Germany Endocrinology Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 47. Germany Endocrinology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Endocrinology Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 49. France Endocrinology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Endocrinology Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 51. U.K. Endocrinology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Endocrinology Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 53. Italy Endocrinology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Endocrinology Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 55. Russia Endocrinology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Endocrinology Drugs Market Share by Type in 2019
Figure 57. Europe Endocrinology Drugs Market Share by Application in 2019
Figure 58. Asia Pacific Endocrinology Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 59. Asia Pacific Endocrinology Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Endocrinology Drugs Sales Market Share by Region in 2019
Figure 61. Asia Pacific Endocrinology Drugs Revenue Market Share by Region in 2019
Figure 62. China Endocrinology Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 63. China Endocrinology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Endocrinology Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 65. Japan Endocrinology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Endocrinology Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 67. South Korea Endocrinology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Endocrinology Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 69. India Endocrinology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Endocrinology Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 71. Australia Endocrinology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Endocrinology Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 73. Taiwan Endocrinology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Endocrinology Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 75. Indonesia Endocrinology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Endocrinology Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 77. Thailand Endocrinology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Endocrinology Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 79. Malaysia Endocrinology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Endocrinology Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 81. Philippines Endocrinology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Endocrinology Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 83. Vietnam Endocrinology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Endocrinology Drugs Market Share by Type in 2019
Figure 85. Asia Pacific Endocrinology Drugs Market Share by Application in 2019
Figure 86. Latin America Endocrinology Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 87. Latin America Endocrinology Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Endocrinology Drugs Sales Market Share by Country in 2019
Figure 89. Latin America Endocrinology Drugs Revenue Market Share by Country in 2019
Figure 90. Mexico Endocrinology Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 91. Mexico Endocrinology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Endocrinology Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 93. Brazil Endocrinology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Endocrinology Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 95. Argentina Endocrinology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Endocrinology Drugs Market Share by Type in 2019
Figure 97. Latin America Endocrinology Drugs Market Share by Application in 2019
Figure 98. Middle East and Africa Endocrinology Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 99. Middle East and Africa Endocrinology Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Endocrinology Drugs Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Endocrinology Drugs Revenue Market Share by Country in 2019
Figure 102. Turkey Endocrinology Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 103. Turkey Endocrinology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Endocrinology Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 105. Saudi Arabia Endocrinology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Endocrinology Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 107. U.A.E Endocrinology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Endocrinology Drugs Market Share by Type in 2019
Figure 109. Middle East and Africa Endocrinology Drugs Market Share by Application in 2019
Figure 110. North America Endocrinology Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 111. North America Endocrinology Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Endocrinology Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. Europe Endocrinology Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Endocrinology Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Asia Pacific Endocrinology Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Endocrinology Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Latin America Endocrinology Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Endocrinology Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 119. Middle East and Africa Endocrinology Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
ヒト成長ホルモン治療薬の世界市場（～2026年） Market Analysis and Insights: Global Human Growth Hormone Drugs Market The global Human Growth Hormone Drugs market size is projected to reach US$ 253.9 million by 2026, from US$ 243 million in 2020, at a CAGR of 4.2%% during 2021-2026. Global Human Growth Hormone Drugs Scope and Market Size Human G…- ヒトマイクロバイオームベース薬剤・診断の世界市場（～2026年） The modern approach involves exploiting the interaction between humans and the bacteria that live in or on the body to develop new drugs and therapies to treat chronic diseases such as diabetes. These microbiomes derived drugs help the physician in better diagnosis of the illness. Rising cases of ch…
- 泌尿生殖器治療薬の世界市場（～2026年） A medical science concerned with the study and treatment of diseases of the genital and urinary organs, especially sexually transmitted diseases. The growing prevalence of genitourinary disorders is presumed to be the high rendering impact driver of this vertical. In addition, increasing number of p…
- 糖尿病治療装置・薬剤の世界市場（～2026年） Diabetes Care Devices & Drugs is used to treat diabetes equipment and drugs. The global diabetes care devices & drugs market is mainly driven by thereasingidence & prevalence of diabetes, technological advancements, rising obesity rate, andreasingdentary lifestyle & improper diet. Market Analysis an…
- ヒト呼吸器合胞体ウイルス薬の世界市場（～2026年） Human respiratory syncytial virus (HRSV) is a syncytial virus that causes respiratory tract infections. It is a major cause of lower respiratory tract infections and hospital visits during infancy and childhood. A prophylactic medication, palivizumab, can be employed to prevent HRSV in preterm (unde…